Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
phospholipase/atrofi
Länken sparas på Urklipp
6 resultat
Method of preparing a cake using phospholipase
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
RELATED APPLICATIONS
This application is the U.S. National Phase filing under 35 U.S.C. .sctn.371 of PCT/EP2007/058418, filed Aug. 14, 2007, entitled "Method of Preparing a Cake Using Phospholipase", which designated the United States and was published in English on Mar. 6, 2008, which claims
Cloning, expression and use of acid phospholipases
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The invention relates to new DNA sequences which code for polypeptides having phospholipase activity essentially without lipase activity. The invention further relates to new polypeptides having phospholipase activity essentially without lipase activity. These polypeptides are acid phospholipases
Cloning, expression and use of acid phospholipases
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The invention relates to new DNA sequences which code for polypeptides having phospholipase activity essentially without lipase activity. The invention further relates to new polypeptides having phospholipase activity essentially without lipase activity. These polypeptides are acid phospholipases
Inhibition of phospholipase A.sub.2 to reduce neuronal cell death
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
The invention relates to methods for inhibiting cell death in mammalian cells, particularly in neuronal cells, by administering a suitable inhibitor of phospholipase A.sub.2 activity, typically an inhibitor of cPLA.sub.2 (cytosolic phospholipase A.sub.2); the invention also provides
Phospholipase A.sub.2-inhibitory peptide with anti-arthritic and neuroprotective activities
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
The invention relates to novel peptide molecules and more specifically to a phospholipase A-inhibitory peptide, its synthetic homologs and derivatives thereof.
BACKGROUND
Group IIA Secretory phospholipase (sPLA.sub.2-IIA) is known to be proinflammatory in vivo (Cirino, G., et al.
Use of lysophosphatidylethanolamine (18.1) and lysophosphatidylinositol to retard senescence and to enhance fruit ripening
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
Various chemical and biological agents are currently being used on commercially grown fruit to control the timing of fruit ripening. Such agents can be used for a variety of purposes. One purpose is to synchronize the ripening of fruit to assist in efficient harvesting of
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
